The present study hypothesis was that eptifibatide offered further antiplatelet efficacy above clopidogrel in non–ST-elevation myocardial infarction (NSTEMI) patients before an expeditive coronary intervention.
Dalby MC, G. Montalescot, C. Bal dit Sollier, E. Vicaut, T. Soulat, J-P. Collet, R. Choussat, V. Gallois, G Drobinski, L. Drouet, D Thomas. Eptifibatide provides additional platelet inhibition in non ST-Elevation Myocardial Infarction patients already treated with aspirin and clopidogrel: Results of the PEACE study. J Am Coll Cardiol. 2004 Jan 21;43(2):162-8